Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-up
Condition(s):Schizophrenia; Psychotic Disorders; PsychosisLast Updated:January 14, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Schizophrenia; Psychotic Disorders; PsychosisLast Updated:January 14, 2020Unknown status
Condition(s):Schizophrenia; Psychosis; Metabolic SyndromeLast Updated:December 16, 2020Unknown status
Condition(s):Schizophrenia; Psychosis; Chronic Respiratory DiseaseLast Updated:December 16, 2020Unknown status
Condition(s):Schizophrenia; Psychotic Disorders; PsychosisLast Updated:July 10, 2019Unknown status
Condition(s):Schizophrenia; Schizophrenia Relapse; Schizophrenia Spectrum and Other Psychotic DisordersLast Updated:January 14, 2020Unknown status
Condition(s):SchizophreniaLast Updated:January 14, 2020Unknown status
Condition(s):Schizophrenia; Mental Disorders; Psychotic DisordersLast Updated:February 17, 2020Completed
Condition(s):Metabolic Syndrome; Mental DisordersLast Updated:February 7, 2020Unknown status
Condition(s):Schizophrenia; Psychotic DisordersLast Updated:March 14, 2017Completed
Condition(s):Schizophrenia; Psychotic DisordersLast Updated:February 12, 2020Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.